The FDA’s Center for Drug Evaluation and Research is offering a grant to support the Heart Failure Collaboratory. This grant allows for the submission of applications aimed at furthering research in the area of heart failure. The closing date for applications is January 22, 2020. The grant provides an opportunity for researchers to contribute towards advancements in the field of cardiovascular and renal products.
Opportunity ID: 322674
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-20-005 |
| Funding Opportunity Title: | Heart Failure Collaboratory (R18) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 21, 2019 |
| Last Updated Date: | Nov 21, 2019 |
| Original Closing Date for Applications: | Jan 22, 2020 |
| Current Closing Date for Applications: | Jan 22, 2020 |
| Archive Date: | Feb 21, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,150,000 |
| Award Floor: | $150,000 |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Independent school districts County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Eligible OrganizationsHigher Education Institutions• Public/State Controlled Institutions of Higher Education • Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: • Hispanic-serving Institutions• Historically Black Colleges and Universities (HBCUs)• Tribally Controlled Colleges and Universities (TCCUs) • Alaska Native and Native Hawaiian Serving Institutions• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher Education• Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations• Small Businesses• For-Profit Organizations (Other than Small Businesses)Governments• State Governments • County Governments• City or Township Governments• Special District Governments• Indian/Native American Tribal Governments (Federally Recognized) • Indian/Native American Tribal Governments (Other than Federally Recognized)• U.S. Territory or PossessionOther• Independent School Districts• Public Housing Authorities/Indian Housing Authorities• Native American Tribal Organizations (other than Federally recognized tribal governments)• Faith-based or Community-based Organizations• Regional Organizations |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), Division of Cardiovascular and Renal Products (DCRP) is announcing its intent to accept and consider applications for the award of a grant to support the Heart Failure Collaboratory |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shashi Malhotra
Grants Management Specialist Phone 2404027592 Email:shashi.malhotra@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Shashi Malhotra Grants Management Specialist Phone 2404027592 Email: shashi.malhotra@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-20-005 | FORM E | PKG00256774 | Nov 21, 2019 | Jan 21, 2020 | View |
Package 1
Mandatory forms
322674 RR_SF424_2_0-2.0.pdf
322674 PHS398_CoverPageSupplement_4_0-4.0.pdf
322674 RR_OtherProjectInfo_1_4-1.4.pdf
322674 PerformanceSite_2_0-2.0.pdf
322674 RR_KeyPersonExpanded_2_0-2.0.pdf
322674 RR_Budget_1_4-1.4.pdf
322674 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322674 RR_SubawardBudget30_1_4-1.4.pdf
322674 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
